Convening notice & Agenda

Dear Shareholder,

The board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) hereby invites you to attend the Extraordinary General Meeting on 24.04.2023 (the “EGM”) that will take place at the offices of the Company at Siriusdreef 17, 2123 WT Hoofddorp. The meeting will start at 14:00 hours CEST and is to be attended physically. Registration will start at 13:00 hours CEST.

Read More

IGEA appoints new Chief Financial Officer

Hoofddorp, the Netherlands, 08 December 2022. IGEA Pharma N.V. (SIX: IGPH) today appointed Diego Fiorentini as new CFO of IGEA Pharma, filling a void that was ad interim covered by the previous CEO.

Read More

Minutes of the AGM 1 December 2022

Minutes of the Annual General Meeting (the ‘Meeting‘) of IGEA Pharma N.V., a public limited company (naamloze vennootschap), having its registered office in Amsterdam (the Netherlands), and address at: (2132 WT) Hoofddorp, Siriusdreef 17, registered with the Commercial Register of the Chamber of Commerce under number 70212821 (the ‘Company‘), held via (i) Zoom and (ii) in the meeting room next to the Company’s office with address at Hoofddorp Transpolis, Polarisavenue 1, (2123 JH) Hoofddorp (the Netherlands) on 1 December 2022 at 11.00 hours CEST.

Read More

Convening Notice and Agenda

The board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) hereby invites the shareholders to attend the annual general meeting on 1 December 2022 (the “AGM”), at the offices of the Company at Siriusdreef 17, 2123 WT Hoofddorp, the Netherlands. The meeting will start at 11:00 hours CET. Registration will start at 10:30 hours CET.

Read More